These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 7138678

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. The significance of low antithrombin III levels in cirrhosis.
    Dumitraşcu DL, Radu D, Vonica A.
    Rom J Intern Med; 1991; 29(3-4):151-4. PubMed ID: 1784943
    [Abstract] [Full Text] [Related]

  • 43. Pattern of steroid resistant nephrotic syndrome in children living in the kingdom of Saudi Arabia: a single center study.
    Kari JA, Halawani M, Mokhtar G, Jalalah SM, Anshasi W.
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):854-7. PubMed ID: 19736491
    [Abstract] [Full Text] [Related]

  • 44. Albumin, fibrinogen, prothrombin and antithrombin III variations in blood, urines and liver in rat nephrotic syndrome (Heymann nephritis).
    Girot R, Jaubert F, Leon M, Bellon B, Aiach M, Josso F, Lepelletier O, Beguin S, Monnet JP.
    Thromb Haemost; 1983 Feb 28; 49(1):13-7. PubMed ID: 6601862
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Increased levels of protein C activity, protein C concentration, total and free protein S in nephrotic syndrome.
    Vaziri ND, Alikhani S, Patel B, Nguyen Q, Barton CH, Gonzales EV.
    Nephron; 1988 Feb 28; 49(1):20-3. PubMed ID: 3132621
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Low plasma pyridoxal-5'-phosphate levels in children with the nephrotic syndrome.
    van Buuren AJ, Shephard GS, Labadarios D.
    S Afr Med J; 1985 Mar 02; 67(9):329-32. PubMed ID: 3983785
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Significance of antithrombin III in kidney diseases].
    Schrader J, Köstering H, Scheler F.
    Behring Inst Mitt; 1986 Feb 02; (79):216-30. PubMed ID: 3718408
    [Abstract] [Full Text] [Related]

  • 56. Reduced alpha-2-antiplasmin levels in the nephrotic syndrome.
    Francis RB, Sandler RM, Levitan D, Feinstein EI, Massry SG, Feinstein DI.
    Nephron; 1985 Feb 02; 39(4):325-9. PubMed ID: 3157072
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S, Zdrojewski Z, Jagodzinski P, Rutkowski B.
    Scand J Urol Nephrol; 2007 Feb 02; 41(3):237-42. PubMed ID: 17469034
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.